| HistoRx Receives Key Patent on Application of AQUA(R) Technology to Personalized Medicine (PR Newswire) HistoRx , Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers. Â U.S. us.rd.yahoo.com |
Glaxo Withheld Avandia Risk Data A former FDA official said GlaxoSmithKline withheld from regulators information suggesting Avandia posed an increased risk for serious health problems. online.wsj.com |
Humana's Net Jumps 21% Humana said profit jumped 21% on improved revenue as membership increased. The managed-care provider raised its 2010 earnings target again. online.wsj.com |
Amgen Recalls Some Procrit, Epogen Amgen is recalling certain lots of anemia drugs Epogen and Procrit because they may contain "extremely thin" glass flakes. online.wsj.com |
Enzo Biochem Reports Fourth Quarter and Year End Results [Business Wire] - Enzo Biochem, Inc. today reported results for the fiscal fourth quarter, consistent with our announcement on September 20, 2010, and for the year ended July 31, 2010. us.rd.yahoo.com |